References
- Pisani C. V.H., Kovach J. S., Kita H., et al. Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patient with cancer. Blood 1991; 78(6)1538–1544
- Nurnberger W., Willers R., Burdach S., Gobel U. Risk factors for capillary leakage syndrome after bone marrow transplantation. Ann. Hematol. 1997; 74(5)221–224
- Aamout M. A., Wang E. A., Clark S. C., et al. Human recombinant granulocyte-macrophage colony-stimulating factor increases cell to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J Clin. Invest. 1986; 78: 597–601
- Brandt J. S., Peters W. P., Atwater S. K., et al. Effect of recombinant human recombinant granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl. J. Med. 1988; 318: 869–876
- Arning M., Kliche K. O., Schneider W. GM-CSF therapy and capillary-leak syndrome. Ann Hematol. 1991; 62: 83
- Vial T., Descotes J. Clinical toxicity of cytokines used as hematopoietic growth factors. Drug Saf. 1995; 13: 371–406
- Oeda E., Shinohara K., Kamei S., et al. Capillary leak syndrome likely the results of granulocyte colony-stimulating factor after high-dose chemotherapy. Int Med. 1994; 33(2)1115–1119
- Heitger A., Maurer K., Neu N., Fink F. M. Letter to the Editor: Capillary leak syndrome in a patient with septicemia and granulocyte-colony-stimulating factor (G-CSF)-induced accelerated granulopoiesis. Med. Pediatr. Oncol. 1998; 31: 126–129
- Lee C. K., Gingrich R. D., Hohl R. J., et al. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 1995; 16: 175–182
- Emminger W., Emminger-Schmidmeier W., Peters C., et al. Capillary leak syndrome during low dose granulocyte-macrophage colony-stimulating factor (rhGM-CSF) treatment of a patient in a continuous febrile state. Blut 1990; 61: 219–221
- Ohsaka A., Kitagava S., Sakamoto S., et al. In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma. Blood 1989; 74(8)2743–2748
- Fischer A., Seger R., Durandy A., et al. Deficiency of the adhesive protein complex lymphocyte function antigen 1, complement receptor type 3, glycoprotein p 150, 95 in a girl with recurrent bacterial infections. Effect on phagocytic cells and lymphocyte functions. J. Clin. Invest. 1985; 76: 2385